VICENTA ALBARRAL ÁVILA

Dr. VICENTA ALBARRAL ÁVILA

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2016 in Systematic and Applied Microbiology
Verified
Journal Article
Closed access
ASAriadna Sanglas
Ariadna Sanglas
VÁVICENTA ALBARRAL ÁVILA
VICENTA ALBARRAL ÁVILA
MFMaribel Farfán
Maribel Farfán
JLJ. Gaspar Lorén
J. Gaspar Lorén
MFM. Carmen Fusté
M. Carmen Fusté

22 August 2012
Verified
Book Chapter
Open access
PDF file
MCM Carmen
M Carmen
MFMaribel Farfán
Maribel Farfán
DMDavid Miñana-Galbis
David Miñana-Galbis
VÁVICENTA ALBARRAL ÁVILA
VICENTA ALBARRAL ÁVILA
ASAriadna Sanglas
Ariadna Sanglas
JGJos Gaspar
Jos Gaspar

14 August 2026 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
VÁVICENTA ALBARRAL ÁVILA
VICENTA ALBARRAL ÁVILA
Anna Nardi RicartAnna Nardi Ricart
Anna Nardi Ricart
Aitor Caballero-RománAitor Caballero-Román
Aitor Caballero-Román
LPLara Martinez Pettina
Lara Martinez Pettina
DMDavid Miñana-Galbis
David Miñana-Galbis
MMMontserrat Miñarro
Montserrat Miñarro
Background/Objectives: Antimicrobial resistance is a critical threat to global public health. Eugenol is a bioactive compound with broad-spectrum antimicrobial activity that has attracted increasing interest as a naturally derived antimicrobial agent with potential complementary applications to conventional antibiotics, but its clinical application is severely limited by its high volatility, low water solubility and thermo-oxidative instability. The main objective of this study was to develop eugenol-loaded microparticles using a ternary biopolymer matrix, to characterise their main physicochemical properties, and to evaluate their in vitro antimicrobial efficacy against clinically relevant bacterial reference strains. Methods: The microparticles were formulated from an emulsion of maltodextrin, gum arabic and soy lecithin, and encapsulated using a spray-drying technique. Product recovery, particle morphology assessed by scanning electron microscopy (SEM), particle size distribution determined by laser diffraction, and encapsulation efficiency quantified by GC-FID were analysed. Subsequently, antimicrobial activity was evaluated by comparing the microparticles with free eugenol using agar well diffusion and broth microdilution assays to determine the minimum inhibitory concentration (MIC) against eight bacterial strains. Results: The spray-drying process achieved a product recovery of 61.88% and an encapsulation efficiency of 52.45%. The resulting microparticles exhibited a smooth, spherical morphology with diameters of less than 20 µm. In microbiological assays, microencapsulation significantly reduced MIC values by 4- to 16-fold compared with free eugenol for susceptible strains. The formulation exhibited potent activity against most of the Gram-positive and Gram-negative pathogens tested, except for Pseudomonas aeruginosa, which remained resistant to both formulations. Conclusions: The encapsulation of eugenol in this optimised biopolymer matrix substantially improved its antimicrobial efficacy against the tested bacterial strains. These findings highlight the potential of spray-dried eugenol microparticles as a promising antimicrobial formulation and provide a basis for their further development for topical applications. Further studies are warranted to evaluate their pharmaceutical performance and antimicrobial mechanisms.

24 October 2026 in Food and Bioprocess Technology
Verified
Journal Article
Closed access
PDF file
César Burgos-DíazCésar Burgos-Díaz
César Burgos-Díaz
YMYohanna Mosi-Roa
Yohanna Mosi-Roa
FLFernando Leal-Calderon
Fernando Leal-Calderon
Manuel Chacón-FuentesManuel Chacón-Fuentes
Manuel Chacón-Fuentes
Mauricio Opazo-NavarreteMauricio Opazo-Navarrete
Mauricio Opazo-Navarrete
MBMariela Bustamante
Mariela Bustamante